[Form 4] MDWerks, Inc. Insider Trading Activity

Rhea-AI Filing Summary

MDWerks, Inc. director Timothy Brocopp reported an acquisition of common stock through an equity grant. He received 85,575 shares of common stock at a stated value of $0.15 per share on a grant/award basis, not an open-market purchase. Following this grant, his direct holdings increased to 3,076,252 common shares.

The shares were issued on a quarterly basis under his Employment Agreement dated November 18, 2024 and granted pursuant to the MDWerks, Inc. 2025 Equity Incentive Plan. The board of directors approved the grant, which was made in accordance with Rule 16b-3 under the Securities Exchange Act of 1934.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Brocopp Timothy

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	85,575	$0.15	$13K

Holdings After Transaction: Common Stock — 3,076,252 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Brocopp Timothy

(Last) (First) (Middle)

411 WALNUT STREET, SUITE 20125

(Street)

GREEN COVE SPRINGS, FL 32043

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MDWerks, Inc. [ MDWK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/23/2026		A		85,575(1)	A	$0.15	3,076,252	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the grant of shares of common stock issued on a quarterly basis pursuant to the Employment Agreement entered into between Reporting Person and the Issuer on November 18, 2024 and issued under the MDWerks, Inc. 2025 Equity Incentive Plan. The grant of shares was approved by the Issuer's board of directors and issued in accordance with Rule 16b-3 promulgated under the Securities Exchange Act of 1934, as amended.

	/s/ Timothy Brocopp	02/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did MDWerks (MDWK) director Timothy Brocopp report in this Form 4?

Director Timothy Brocopp reported receiving an equity grant of 85,575 MDWerks common shares. The award was issued at a stated value of $0.15 per share and increased his direct holdings to 3,076,252 shares after the transaction.

Was the MDWerks (MDWK) Form 4 transaction a market purchase or sale?

The Form 4 shows a grant or award acquisition, not a market trade. Brocopp received 85,575 common shares as compensation, issued under the 2025 Equity Incentive Plan, rather than buying or selling shares on the open market.

What agreement governs Timothy Brocopp’s stock grant at MDWerks (MDWK)?

The stock grant is issued on a quarterly basis under an Employment Agreement dated November 18, 2024. This agreement provides for equity compensation, delivered as MDWerks common shares pursuant to the company’s 2025 Equity Incentive Plan.

How many MDWerks (MDWK) shares does Timothy Brocopp hold after this grant?

After the reported grant, Timothy Brocopp directly holds 3,076,252 MDWerks common shares. This total reflects the addition of the 85,575 shares awarded in the transaction disclosed in the Form 4 filing.

Under which plan and rule was the MDWerks (MDWK) equity grant made?

The grant was made under the MDWerks, Inc. 2025 Equity Incentive Plan and approved by the board. It was issued in accordance with Rule 16b-3 under the Securities Exchange Act of 1934, which governs insider-related equity awards.

What is the reported value per share of the MDWerks (MDWK) stock grant?

The Form 4 reports a transaction price of $0.15 per MDWerks common share for the grant. This stated value is used for the 85,575-share equity award issued to director Timothy Brocopp under his employment-related compensation arrangement.